Literature DB >> 2547889

Human neutrophils activated by interferon-gamma and tumour necrosis factor-alpha kill Entamoeba histolytica trophozoites in vitro.

M Denis1, K Chadee.   

Abstract

The interaction between cytokine-activated human neutrophils and Entamoeba histolytica trophozoites was studied as well as the mechanism(s) involved. Treatment of neutrophils with rIFN-gamma alone allowed them to kill 30% of E. histolytica trophozoites; however, rIFN-gamma and rTNF-alpha pretreatments in combination increased neutrophil killing to 70%. In the absence of direct contact between neutrophils and amebae, rIFN-gamma-treated neutrophils were shown to kill 70% of amebae, and rIFN-gamma- and rTNF-alpha-treated neutrophils killed 97% of amebae. Neutrophil enhancement of amebicidal activity following cytokine treatments was correlated with increased neutrophil resistance to amebic contact-dependent killing and was shown to be 73% H2O2 dependent.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547889     DOI: 10.1002/jlb.46.3.270

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  37 in total

1.  CD4+ and CD8+ T cell- and IL-17-mediated protection against Entamoeba histolytica induced by a recombinant vaccine.

Authors:  Xiaoti Guo; Lisa Barroso; David M Lyerly; William A Petri; Eric R Houpt
Journal:  Vaccine       Date:  2010-11-21       Impact factor: 3.641

Review 2.  Crosstalk at the initial encounter: interplay between host defense and ameba survival strategies.

Authors:  Xiaoti Guo; Eric Houpt; William A Petri
Journal:  Curr Opin Immunol       Date:  2007-08-16       Impact factor: 7.486

3.  Sexual dimorphism in the control of amebic liver abscess in a mouse model of disease.

Authors:  Hannelore Lotter; Thomas Jacobs; Iris Gaworski; Egbert Tannich
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Protection against intestinal amebiasis by a recombinant vaccine is transferable by T cells and mediated by gamma interferon.

Authors:  Xiaoti Guo; Lisa Barroso; Steven M Becker; David M Lyerly; Thomas S Vedvick; Steven G Reed; William A Petri; Eric R Houpt
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

5.  Association between TNF-alpha and Entamoeba histolytica diarrhea.

Authors:  Kristine M Peterson; Jianfen Shu; Priya Duggal; Rashidul Haque; Dinesh Mondal; William A Petri
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

Review 6.  The immunology of parasite infections in immunocompromised hosts.

Authors:  T Evering; L M Weiss
Journal:  Parasite Immunol       Date:  2006-11       Impact factor: 2.280

7.  Resistance to intestinal Entamoeba histolytica infection is conferred by innate immunity and Gr-1+ cells.

Authors:  Amon Asgharpour; Carol Gilchrist; Duza Baba; Shinjiro Hamano; Eric Houpt
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

8.  The tumor necrosis factor alpha-stimulating region of galactose-inhibitable lectin of Entamoeba histolytica activates gamma interferon-primed macrophages for amebicidal activity mediated by nitric oxide.

Authors:  R Séguin; B J Mann; K Keller; K Chadee
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

9.  A synthetic tumor necrosis factor-alpha agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chabaudi infection in mice.

Authors:  L M Kumaratilake; D A Rathjen; P Mack; F Widmer; V Prasertsiriroj; A Ferrante
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

Review 10.  Host-pathogen interaction in amebiasis and progress in vaccine development.

Authors:  C D Huston; W A Petri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.